Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Adam Elnaggar"'
Autor:
Inbal Barbiro, Amita Patnaik, Manish Sharma, Drew Rasco, Ryan Sullivan, Ecaterina Dumbrava, Pierre Ferre, Gini Fleming, Kyriakos Papadopoulos, Daniel Vaena, Adam ElNaggar, Adeboye Adewoye, Robina Smith, Emerson Lim
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/79090e9b14894f908bab8530154d36f2
Autor:
Adam, ElNaggar, David, Robins, Yasmine, Baca, David, Arguello, Michael, Ulm, Rebecca, Arend, Gina, Mantia-Smaldone, Christina, Chu, Ira, Winer, Rob, Holloway, Tom, Krivak, Nathaniel, Jones, Valerie, Galvan-Turner, Thomas J, Herzog, Jubilee, Brown
Publikováno v:
Gynecologic Oncology. 167:306-313
Low grade serous ovarian cancer (LGSOC) differs from high grade serous in terms of pathogenesis, molecular, genetic, and clinical features. Molecular studies have been hampered by small sample sizes, heterogenous histology, and lack of comprehensive
Autor:
Shivaram Cumarasamy, George Laliotis, Elshaddai White, Jordan Rich, Punashi Dutta, Shruti Sharma, Mark Calhoun, Adam Elnaggar, Minetta Liu, Kyrollis Attalla, Reza Mehrazin, Peter Wiklund, John Sfakianos
Publikováno v:
Journal of Urology. 209
Autor:
Naixin Zhang, Catherine Coffman, Ben Wilson, Joann Gold, Scott Baum, Todd Tillmanns, Adam ElNaggar
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
ObjectiveRadiofrequency ablation and microwave ablation are used to vaporize tumors not amenable to surgical resection. We sought to evaluate the safety and efficacy of radiofrequency and microwave ablation for the treatment of isolated lesions in pa
Autor:
Sarah A. Ackroyd, David Arguello, Pilar Ramos, Haider Mahdi, Adam ElNaggar, Ira Winer, Rob Holloway, Thomas Krivak, Nathaniel Jones, Valerie Galvan Turner, Thomas Herzog, Christina Chu, Jubilee Brown, Gina Mantia-Smaldone
Publikováno v:
Gynecologic oncology.
Advanced clear cell gynecologic malignancies remain among the most challenging diseases to manage. We evaluated ovarian and endometrial clear cell carcinoma (OCCC and ECCC) specimens using comprehensive sequencing technology to identify mutational ta
Autor:
Sia Viborg Lindskrog, George Laliotis, Karin Birkenkamp-Demtröder, Iver Nordentoft, Philippe Lamy, Elshaddai Z. White, Natalia Pajak, Tine G. Andreasen, Punashi Dutta, Meenakshi Malhotra, Shruti Sharma, Mark Calhoun, Adam ElNaggar, Minetta C. Liu, Mads Agerbæk, Jørgen B. Jensen, Lars Dyrskjøt
Publikováno v:
Cancer Research. 83:5600-5600
Background: Standard treatment of localized muscle invasive bladder cancer (MIBC) is neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC); however, only 40-50% respond to NAC and approx. 50% experience relapse. Evaluation of treatment e
Autor:
Arnab Basu, Revathi Kollipara, Sumedha Sudhaman, Tamara Mahmood, Natalia Pajak, Carcia Carson, Punashi Dutta, Mark Calhoun, Adam ElNaggar, Minetta C. Liu, James Ferguson, Charles Peyton, Soroush Rais-Bahrami, Alan Tan
Publikováno v:
Journal of Clinical Oncology. 41:715-715
715 Background: Treatment response monitoring is key to effective disease management for patients with advanced (RCC) and can potentially improve clinical outcomes. Circulating tumor DNA (ctDNA) has shown promise as a biomarker in the early identific
Autor:
Lars Dyrskjøt, George Laliotis MD, PhD, Iver Nordentoft, Karin Birkenkamp-Demtröder, Sia Viborg Lindskrog, Philippe Lamy, Elshaddai White, Natalia Pajak, Tine Ginnerup Andreasen, Punashi Dutta, Shruti Sharma, Mark Calhoun, Adam ElNaggar, Minetta C. Liu, Mads Agerbaek, Jørgen Bjerggaard Jensen
Publikováno v:
Journal of Clinical Oncology. 41:563-563
563 Background: Muscle-invasive bladder cancer (MIBC) accounts for ~25–30% of all bladder cancer diagnoses. With neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) as standard-of-care, the 5-year survival rate ranges from 40%–60%.
Autor:
Albert Jang, Ellen B. Jaeger, Grant Rauterkus, Alexandra Lieberman, Minqi Huang, Sree M Lanka, Sumedha Sudhaman, Tamara Mahmood, Natalia Pajak, Mark Calhoun, Kaoutar Tlemcani, Adam ElNaggar, Minetta Liu, Brian E. Lewis, Jodi Lyn Layton, A. Oliver Sartor, Pedro C. Barata
Publikováno v:
Journal of Clinical Oncology. 41:721-721
721 Background: Current methodologies for monitoring treatment response are largely based on conventional scans and/or tumor biopsies, which may be limited in their ability to accurately assess disease burden at the molecular level. Circulating tumor
Publikováno v:
Gynecologic Oncology. 166:S163